UniProt ID | HBB_HUMAN | |
---|---|---|
UniProt AC | P68871 | |
Protein Name | Hemoglobin subunit beta | |
Gene Name | HBB | |
Organism | Homo sapiens (Human). | |
Sequence Length | 147 | |
Subcellular Localization | ||
Protein Description | Involved in oxygen transport from the lung to the various peripheral tissues.; LVV-hemorphin-7 potentiates the activity of bradykinin, causing a decrease in blood pressure.; Spinorphin: functions as an endogenous inhibitor of enkephalin-degrading enzymes such as DPP3, and as a selective antagonist of the P2RX3 receptor which is involved in pain signaling, these properties implicate it as a regulator of pain and inflammation.. | |
Protein Sequence | MVHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | N-pyruvate 2-iminyl-valine | ------MVHLTPEEK ------CCCCCHHHH | 5.21 | - | |
2 | Acetylation | ------MVHLTPEEK ------CCCCCHHHH | 5.21 | - | |
2 | Other | ------MVHLTPEEK ------CCCCCHHHH | 5.21 | - | |
2 | N-linked_Glycosylation | ------MVHLTPEEK ------CCCCCHHHH | 5.21 | 635569 | |
5 | Phosphorylation | ---MVHLTPEEKSAV ---CCCCCHHHHHHH | 17.49 | 23025827 | |
9 | N-linked_Glycosylation | VHLTPEEKSAVTALW CCCCHHHHHHHHHHH | 41.89 | 7358733 | |
9 | Glycation | VHLTPEEKSAVTALW CCCCHHHHHHHHHHH | 41.89 | - | |
9 | Acetylation | VHLTPEEKSAVTALW CCCCHHHHHHHHHHH | 41.89 | 7666987 | |
10 | Phosphorylation | HLTPEEKSAVTALWG CCCHHHHHHHHHHHC | 31.11 | 25072903 | |
13 | Phosphorylation | PEEKSAVTALWGKVN HHHHHHHHHHHCCCC | 18.75 | 24702127 | |
18 | Acetylation | AVTALWGKVNVDEVG HHHHHHCCCCHHHCC | 21.03 | 20167786 | |
18 | N-linked_Glycosylation | AVTALWGKVNVDEVG HHHHHHCCCCHHHCC | 21.03 | 7358733 | |
18 | Glycation | AVTALWGKVNVDEVG HHHHHHCCCCHHHCC | 21.03 | - | |
36 | Phosphorylation | LGRLLVVYPWTQRFF HHHHEEHHHHHHHHH | 5.88 | 21082442 | |
36 | Nitration | LGRLLVVYPWTQRFF HHHHEEHHHHHHHHH | 5.88 | - | |
39 | Phosphorylation | LLVVYPWTQRFFESF HEEHHHHHHHHHHHH | 12.83 | 28857561 | |
45 | O-linked_Glycosylation | WTQRFFESFGDLSTP HHHHHHHHHCCCCCC | 29.40 | OGP | |
45 | Phosphorylation | WTQRFFESFGDLSTP HHHHHHHHHCCCCCC | 29.40 | 24972180 | |
50 | O-linked_Glycosylation | FESFGDLSTPDAVMG HHHHCCCCCCCHHCC | 42.51 | 20166139 | |
50 | Phosphorylation | FESFGDLSTPDAVMG HHHHCCCCCCCHHCC | 42.51 | 23025827 | |
51 | Phosphorylation | ESFGDLSTPDAVMGN HHHCCCCCCCHHCCC | 32.27 | 23025827 | |
56 | Sulfoxidation | LSTPDAVMGNPKVKA CCCCCHHCCCHHHCC | 4.62 | 21192028 | |
60 | Acetylation | DAVMGNPKVKAHGKK CHHCCCHHHCCCCCE | 61.44 | 4531009 | |
62 | Acetylation | VMGNPKVKAHGKKVL HCCCHHHCCCCCEEE | 40.57 | 7675277 | |
66 | Acetylation | PKVKAHGKKVLGAFS HHHCCCCCEEEHHHH | 29.82 | 30583883 | |
67 | N-linked_Glycosylation | KVKAHGKKVLGAFSD HHCCCCCEEEHHHHH | 47.48 | 7358733 | |
67 | Glycation | KVKAHGKKVLGAFSD HHCCCCCEEEHHHHH | 47.48 | - | |
73 | Phosphorylation | KKVLGAFSDGLAHLD CEEEHHHHHHHHHHH | 30.18 | 23025827 | |
73 | O-linked_Glycosylation | KKVLGAFSDGLAHLD CEEEHHHHHHHHHHH | 30.18 | 20166139 | |
83 | Acetylation | LAHLDNLKGTFATLS HHHHHHCCCHHHHHH | 63.26 | 4531009 | |
85 | Phosphorylation | HLDNLKGTFATLSEL HHHHCCCHHHHHHHH | 14.44 | 23312004 | |
85 | O-linked_Glycosylation | HLDNLKGTFATLSEL HHHHCCCHHHHHHHH | 14.44 | 12556445 | |
88 | Phosphorylation | NLKGTFATLSELHCD HCCCHHHHHHHHCCC | 26.99 | 26657352 | |
90 | Phosphorylation | KGTFATLSELHCDKL CCHHHHHHHHCCCCC | 33.48 | 23025827 | |
94 | S-nitrosylation | ATLSELHCDKLHVDP HHHHHHCCCCCCCCH | 8.46 | 9843411 | |
94 | Glutathionylation | ATLSELHCDKLHVDP HHHHHHCCCCCCCCH | 8.46 | 16051210 | |
94 | S-nitrosocysteine | ATLSELHCDKLHVDP HHHHHHCCCCCCCCH | 8.46 | - | |
94 | Methylation | ATLSELHCDKLHVDP HHHHHHCCCCCCCCH | 8.46 | - | |
96 | Acetylation | LSELHCDKLHVDPEN HHHHCCCCCCCCHHH | 45.98 | 25038526 | |
113 | S-nitrosylation | LLGNVLVCVLAHHFG HHHHHHHHHHHHHHC | 1.49 | 25040305 | |
121 | Glycation | VLAHHFGKEFTPPVQ HHHHHHCCCCCHHHH | 49.03 | - | |
121 | N-linked_Glycosylation | VLAHHFGKEFTPPVQ HHHHHHCCCCCHHHH | 49.03 | 7358733 | |
121 | Acetylation | VLAHHFGKEFTPPVQ HHHHHHCCCCCHHHH | 49.03 | 7669925 | |
124 | Phosphorylation | HHFGKEFTPPVQAAY HHHCCCCCHHHHHHH | 27.98 | 23911959 | |
131 | Nitration | TPPVQAAYQKVVAGV CHHHHHHHHHHHHHH | 16.34 | - | |
131 | Phosphorylation | TPPVQAAYQKVVAGV CHHHHHHHHHHHHHH | 16.34 | 21253578 | |
133 | Acetylation | PVQAAYQKVVAGVAN HHHHHHHHHHHHHHH | 26.46 | 7684877 | |
145 | N-linked_Glycosylation | VANALAHKYH----- HHHHHHHCCC----- | 39.14 | 7358733 | |
145 | Glycation | VANALAHKYH----- HHHHHHHCCC----- | 39.14 | - | |
145 | Acetylation | VANALAHKYH----- HHHHHHHCCC----- | 39.14 | 4531009 | |
146 | Nitration | ANALAHKYH------ HHHHHHCCC------ | 11.68 | - | |
146 | Phosphorylation | ANALAHKYH------ HHHHHHCCC------ | 11.68 | 28857561 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HBB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
2 | N-linked Glycosylation | 7 (5) | E ⇒ V;K | rs334;rs33930165 |
| 27650483 28453575 29381699 |
5 | Phosphorylation | 7 (2) | E ⇒ V;K | rs334;rs33930165 |
| 27650483 28453575 29381699 |
9 | Acetylation | 7 (2) | E ⇒ V;K | rs334;rs33930165 |
| 27650483 28453575 29381699 |
10 | Phosphorylation | 7 (3) | E ⇒ V;K | rs334;rs33930165 |
| 27650483 28453575 29381699 |
13 | Phosphorylation | 7 (6) | E ⇒ V;K | rs334;rs33930165 |
| 27650483 28453575 29381699 |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SELT_HUMAN | SELT | physical | 16169070 | |
HBA_HUMAN | HBA1 | physical | 6644819 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
140700 | Heinz body anemias (HEIBAN) |
613985 | Beta-thalassemia (B-THAL) |
603903 | Sickle cell anemia (SKCA) |
603902 | Beta-thalassemia, dominant, inclusion body type (B-THALIB) |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00893 | Iron Dextran |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Sites of nonenzymatic glycosylation of human hemoglobin A."; Shapiro R., McManus M.J., Zalut C., Bunn H.F.; J. Biol. Chem. 255:3120-3127(1980). Cited for: GLYCATION AT LYS-9; LYS-18; LYS-67; LYS-121 AND LYS-145, AND LACK OFGLYCATION AT LYS-60; LYS-83 AND LYS-96. | |
"The glycosylation of hemoglobin: relevance to diabetes mellitus."; Bunn H.F., Gabbay K.H., Gallop P.M.; Science 200:21-27(1978). Cited for: GLYCATION AT VAL-2. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-131, AND MASSSPECTROMETRY. | |
S-nitrosylation | |
Reference | PubMed |
"Crystal structure of the S-nitroso form of liganded humanhemoglobin."; Chan N.L., Rogers P.H., Arnone A.; Biochemistry 37:16459-16464(1998). Cited for: S-NITROSYLATION AT CYS-94. | |
"S-nitrosohaemoglobin: a dynamic activity of blood involved invascular control."; Jia L., Bonaventura C., Bonaventura J., Stamler J.S.; Nature 380:221-226(1996). Cited for: S-NITROSYLATION AT CYS-94. |